Overall Technical outlook

Price Summary

On 2025-07-16, Eris Lifesciences Limited's stock began at 1745.6, climbed to 1795.0, dropped to 1744.9, and had 1.51% to end at 1771.9, with a volume of 62566 shares.
During the 52-week span, the stock hit a high of 1847.7 and a low of 1006.3.
The future price of ERIS is anticipated to range from 1350.0 to 1880.0, with an expected mean price of 1690.0, according to the recommendations of 10 analysts.

Technicals


Aroon: The bullish trend indicated by Aroon persists, with Aroon Up holding steady at the 100 level. This shows strong market momentum, but further exploration using additional indicators is necessary to confirm the trend's strength and future potential.
ERIS aroon d08a9e
Aroon chart for Eris Lifesciences Limited


Bol. Bands: The BOLL BANDS is showing a neutral stance, with no definitive indication of an upward or downward trend for ERIS. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
ERIS bbands d08a9e
Bolinger Bands chart for Eris Lifesciences Limited


Parabolic SAR: The PSAR for ERIS continues to signal a bullish outlook, establishing a crucial support level that may help sustain the current upward momentum. This level of support suggests that the market is likely to continue trending higher, providing a foundation for ongoing bullish movement.
ERIS psar d08a9e
Parabolic Stop and Reverse chart for Eris Lifesciences Limited


Stochastic: With the K-line exceeding both the D-line and the 80 level, the stochastic indicator is showing a bullish signal. This suggests strong upward momentum, indicating that the market may continue to trend higher. Traders could view this as a sign of ongoing strength in the market.
ERIS stoch d08a9e
Stochastic chart for Eris Lifesciences Limited


Tripple Moving Agerage: The Tripple MOVING AVG is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
ERIS trippleSMA d08a9e
Tripple SMA chart for Eris Lifesciences Limited


When analyzing a company, its fundamentals—such as earnings, management efficiency, and strategic initiatives—must be considered alongside technical data. The context of the industry in which the company operates also plays a key role, as market trends and competitive dynamics can significantly impact performance. By taking a comprehensive approach, combining both fundamental and technical analysis, one can gain a deeper understanding of the company's potential for growth or risk.